The Food and Drug Administration's long-awaited authorization of COVID vaccines for the country's youngest children may be coming soon after the federal agency announced plans to convene its vaccine advisory committee this coming June to discuss that particular topic.
The apex drug controller of India had last month approved Covovax for restricted emergency use among children above 12 years of age under certain conditions